Ledger.Open graph →
SEC Form D · filed June 1, 2017

Iterum Therapeutics Ltd

Offering
$65.5M
Sold
$45.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DUBLIN, Ireland
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (31)

Corey N. Fishman · Dublin, IrelandExec · Director · PromoterJames I. Healy · Dublin, IrelandDirectorPaul R. Edick · Dublin, IrelandDirectorJudith M. Matthews · Dublin, IrelandExec · PromoterBrenton K. Ahrens · Dublin, IrelandDirectorPatrick J. Heron · Dublin, IrelandDirectorMichael W. Dunne · Dublin, IrelandExec · PromoterRonald M. Hunt · Dublin, IrelandDirectorDavid I. Kelly · Dublin, IrelandDirectorShahzad I. Malik · Dublin, IrelandDirectorMark I. Chin · Dublin, IrelandDirectorCarrie Pumphrey · Columbus, INDirectorIcbp Iv GP, LLC · San Francisco, CAExec · Director · PromoterGeorge Devidze · Columbus, INExec · PromoterRick Dubois · Littleton, COExec · PromoterPatrick Malloy · Indianapolis, INDirectorGreg Nielsen · Round Rock, TXDirectorJorn Van Dijk · Amsterdam, P7DirectorTracy I. Saxton · Dublin, IrelandDirectorRobert M. Steers · NEW YORK, NYExec · Director · PromoterErich A. Mohr · Victoria, British Columbia, CanadaExec · Director · PromoterMichael A. Tharp · Oklahoma City, OKDirectorRobert G. Heard · Oklahoma City, OKDirectorKraettli L. Epperson · Oklahoma City, OKExec · PromoterSteve Chapman · Grand Cayman, Cayman IslandsDirectorDavid B. Blanford · Louisville, KYDirectorJohn Legat · London, United KingdomDirectorPascal Costantini · London, United KingdomDirectorTracy I. Saxton · Dublin, IrelandDirectorShahzad I. Malik · Dublin, IrelandDirectorMark I. Chin · Dublin, IrelandDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗